Disease Domain | Count |
---|---|
Endocrinology and Metabolic Disease | 1 |
Top 5 Drug Type | Count |
---|---|
Unknown | 1 |
Small molecule drug | 1 |
Biological products | 1 |
Top 5 Target | Count |
---|---|
CRHR2(Corticotropin-releasing factor receptor 2) | 2 |
Target |
Mechanism CRHR2 stimulants |
Active Org. Corteria PharmaceuticalsStartup |
Originator Org. Corteria PharmaceuticalsStartup |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism CRHR2 stimulants |
Active Org. Corteria PharmaceuticalsStartup |
Originator Org. Corteria PharmaceuticalsStartup |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org. Corteria PharmaceuticalsStartup |
Originator Org. Corteria PharmaceuticalsStartup |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date- |
Sponsor / Collaborator Corteria PharmaceuticalsStartup |
Start Date10 Sep 2024 |
Sponsor / Collaborator Corteria PharmaceuticalsStartup |
Start Date28 Sep 2022 |
Sponsor / Collaborator Corteria PharmaceuticalsStartup |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
COR-1167 ( CRHR2 ) | Heart Failure More | Phase 1 |
COR-1389 ( CRHR2 ) | Obesity More | Phase 1 |
CORZZZ | Heart Failure More | Preclinical |